EUVIMEDEUVIMED entdecken
Crossref

Knockdown of fat mass and obesity alleviates the ferroptosis in Parkinson's disease through m6A‐NRF2‐dependent manner

Pengfei Pang, Shirong Zhang iD, Xinxin Fan, Shitao Zhang

Cell Biology International · 2024

DOI: 10.1002/cbin.12118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biology International, 2024. Verfasst von Pengfei Pang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Affiliated Hospital of Northwest University, Xi'an, China. Hauptthemen laut MEDLINE: Parkinson Disease, Ferroptosis, Neuroblastoma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Emerging evidence has suggested that N 6 ‐methyladenosine (m 6 A) regulates the pathology of Parkinson's disease (PD). Nevertheless, the function of demethylase fat mass and obesity (FTO) associated pathogenesis is still not fully elucidated. Here, this research findings revealed that m 6 A‐modification was decreased in PD models, meanwhile, the FTO level upregulated in the PD models. Functionally, in N‐methyl‐4‐phenylpyridinium (MPP+) treated SH‐SY5Y cells, the ferroptosis significantly upregulated and FTO silencing mitigated the ferroptosis phenotype. Moreover, in silico assays indicated that nuclear factor erythroid 2‐related factor‐2 (NRF2) acted as the target of FTO, and FTO demethylated the m 6 A modification from NRF2 mRNA. Furthermore, FTO impaired the NRF2 mRNA stability via m 6 A‐dependent pathway. Thus, our findings illustrated an important role of FTO on PD through m 6 A‐NRF2‐ferroptosis manner. Taken together, the study revealed the potential function of FTO on PD nervous system diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseFerroptosisNeuroblastomaHumansNF-E2-Related Factor 2Obesity1-Methyl-4-phenylpyridiniumAlpha-Ketoglutarate-Dependent Dioxygenase FTOAdenine

Stichwörter der Autor:innen

N6-methyladenosineParkinson's diseasefat mass and obesityferroptosisnuclear factor erythroid 2-related factor-2

Substanzen

NF-E2-Related Factor 21-Methyl-4-phenylpyridiniumAlpha-Ketoglutarate-Dependent Dioxygenase FTOAdenineFTO protein, human6-methyladenine

Autor:innen und Institutionen

  • Department of Neurosurgery, The Affiliated Hospital of Northwest University, Xi'an, China.

ORCID-Profile: Shirong Zhang

Zitieren

APA

Pang, P., Zhang, S., Fan, X., & Zhang, S. (2024). Knockdown of fat mass and obesity alleviates the ferroptosis in Parkinson's disease through m6A‐NRF2‐dependent manner. Cell Biology International. https://doi.org/10.1002/cbin.12118

Vancouver

Pang P, Zhang S, Fan X, Zhang S. Knockdown of fat mass and obesity alleviates the ferroptosis in Parkinson's disease through m6A‐NRF2‐dependent manner. Cell Biology International. 2024. doi:10.1002/cbin.12118

BibTeX
@article{Pang2024,
  author = {Pang, Pengfei and Zhang, Shirong and Fan, Xinxin and Zhang, Shitao},
  title = {Knockdown of fat mass and obesity alleviates the ferroptosis in Parkinson's disease through m6A‐NRF2‐dependent manner},
  journal = {Cell Biology International},
  year = {2024},
  doi = {10.1002/cbin.12118}
}
Kostenlos starten →